» Articles » PMID: 33977232

Cyclophilin A Induces Macrophage Apoptosis and Enhances Atherosclerotic Lesions in High-fat Diet-fed Hyperglycemic Rabbits

Overview
Journal FASEB Bioadv
Specialty Biology
Date 2021 May 12
PMID 33977232
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophage apoptosis is a key contributor to the progression of atherosclerosis. Cyclophilin A, a monocyte secretory protein associated with the initiation of atherosclerosis has an inherent nuclease activity. This study reports the mechanism by which cyclophilin A causes apoptosis of macrophages and accelerates the progression of atherosclerosis. Aortic lesion formation and apoptosis were studied in New Zealand White rabbits (NZW) which were fed high-fat diet (HFD) for 12 weeks. Using monocytes and HFD-fed rabbits we demonstrate that cyclophilin A induces mitochondrial membrane potential loss and mitochondrial pore transition protein opening through caspase 3 activation. En face staining revealed a significant increase in the lesion area in HFD-fed rabbits. Levels of glucose, cholesterol and proinflammatory cytokines were higher in these animals compared to rabbits fed with a normal diet. In the aorta of HFD-fed rabbits, medial vascular smooth muscle cells were disorganized and there was a loss of integrity of the endothelium. An 8-fold increase was seen in the number of apoptotic cells in the lesion area of HFD-fed NZW rabbits which were associated with an elevation in plasma cyclophilin A levels. siRNA knockdown of cyclophilin A gene reduced activation of caspase 3 in macrophages. Treatment with cyclosporine A, an inhibitor of cyclophilin A, significantly attenuated apoptosis in macrophages. Our study indicates that inhibitors of proinflammatory cytokines such as cyclophilin A may arrest macrophage apoptosis and result in a regression of advanced atherosclerotic lesions.

Citing Articles

Orphan GPR26 Counteracts Early Phases of Hyperglycemia-Mediated Monocyte Activation and Is Suppressed in Diabetic Patients.

Kichi Z, Natarelli L, Sadeghian S, Boroumand M, Behmanesh M, Weber C Biomedicines. 2022; 10(7).

PMID: 35885041 PMC: 9312814. DOI: 10.3390/biomedicines10071736.


Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.

Sun K, Hong J, Chen D, Luo Z, Li J BMC Gastroenterol. 2022; 22(1):344.

PMID: 35840882 PMC: 9284853. DOI: 10.1186/s12876-022-02423-6.


Current update on theranostic roles of cyclophilin A in kidney diseases.

Hadpech S, Thongboonkerd V Theranostics. 2022; 12(9):4067-4080.

PMID: 35673572 PMC: 9169364. DOI: 10.7150/thno.72948.


Cyclophilin A Impairs Efferocytosis and Accelerates Atherosclerosis by Overexpressing CD 47 and Down-Regulating Calreticulin.

Anandan V, Thulaseedharan T, Suresh Kumar A, Chandran Latha K, Revikumar A, Mullasari A Cells. 2021; 10(12).

PMID: 34944106 PMC: 8700718. DOI: 10.3390/cells10123598.

References
1.
Fan J, Kitajima S, Watanabe T, Xu J, Zhang J, Liu E . Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine. Pharmacol Ther. 2014; 146:104-19. PMC: 4304984. DOI: 10.1016/j.pharmthera.2014.09.009. View

2.
Montague J, Gaido M, Frye C, Cidlowski J . A calcium-dependent nuclease from apoptotic rat thymocytes is homologous with cyclophilin. Recombinant cyclophilins A, B, and C have nuclease activity. J Biol Chem. 1994; 269(29):18877-80. View

3.
Cande C, Vahsen N, Kouranti I, Schmitt E, Daugas E, Spahr C . AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene. 2004; 23(8):1514-21. DOI: 10.1038/sj.onc.1207279. View

4.
Cohen G . Caspases: the executioners of apoptosis. Biochem J. 1997; 326 ( Pt 1):1-16. PMC: 1218630. DOI: 10.1042/bj3260001. View

5.
Tabas I . Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 2009; 10(1):36-46. PMC: 2854623. DOI: 10.1038/nri2675. View